Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, six have given a buy rating and one has issued […]

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP – Get Free Report) has been assigned an average rating of “Moderate Buy” from the five research firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a buy rating and one has given a strong buy […]